To assess whether this effect was phosphatidylinositol 3′-kinase (PI3K)/AKT dependent, we treated human PCa cell lines with either normal or functional loss of PTEN with the PI3K inhibitor, AZD8186. The gene discussed is PTEN; the disease is posterior cortical atrophy.